Marshall Fordyce
2021
In 2021, Marshall Fordyce earned a total compensation of $1.5M as President and Chief Executive Officer at Vera Therapeutics, a 54% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $236,259 |
|---|---|
| Option Awards | $770,343 |
| Salary | $479,099 |
| Total | $1,485,701 |
Fordyce received $770.3K in option awards, accounting for 52% of the total pay in 2021.
Fordyce also received $236.3K in non-equity incentive plan and $479.1K in salary.
Rankings
In 2021, Marshall Fordyce's compensation ranked 7,297th out of 12,406 executives tracked by ExecPay. In other words, Fordyce earned more than 41.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,297 out of 12,406 | 41st |
Division Manufacturing | 3,200 out of 5,492 | 42nd |
Major group Chemicals And Allied Products | 1,418 out of 2,368 | 40th |
Industry group Drugs | 1,262 out of 2,089 | 40th |
Industry Pharmaceutical Preparations | 927 out of 1,536 | 40th |
Source: SEC filing on April 14, 2022.
Fordyce's colleagues
We found two more compensation records of executives who worked with Marshall Fordyce at Vera Therapeutics in 2021.